DK1322321T3 - Anvendelse af S-[2,3-bispalmitoyloxy-(2RS)propyl]cysteinyl-GNNDESNISFKEK (MALP-2) - Google Patents

Anvendelse af S-[2,3-bispalmitoyloxy-(2RS)propyl]cysteinyl-GNNDESNISFKEK (MALP-2)

Info

Publication number: DK1322321T3
Authority: DK; Denmark
Prior art keywords: denotes; gnndesnisfkek; bispalmitoyloxy; malp; cysteinyl
Prior art date: 2000-10-02

Application number

DK01986301T

Other languages

English (en)

Inventor

Peter Muehlradt

Anke Luehrmann

Thomas Tschernig

Reinhard Pabst

Original Assignee

Helmholtz Infektionsforschung

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-02

Filing date

2001-10-02

Publication date

2008-10-13

2001-10-02 Application filed by Helmholtz Infektionsforschung filed Critical Helmholtz Infektionsforschung

2008-10-13 Application granted granted Critical

2008-10-13 Publication of DK1322321T3 publication Critical patent/DK1322321T3/da

Links

DMWMUMWKGKGSNW-OPMCLZTFSA-N (2S)-6-amino-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-4-amino-2-[[2-[[(2R)-2-amino-3-[(2R)-2,3-di(hexadecanoyloxy)propyl]sulfanylpropanoyl]amino]acetyl]amino]-4-oxobutanoyl]amino]-4-oxobutanoyl]amino]-3-carboxypropanoyl]amino]-4-carboxybutanoyl]amino]-3-hydroxypropanoyl]amino]-4-oxobutanoyl]amino]-3-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]-3-phenylpropanoyl]amino]hexanoyl]amino]-4-carboxybutanoyl]amino]hexanoic acid Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](CSC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(O)=O)OC(=O)CCCCCCCCCCCCCCC DMWMUMWKGKGSNW-OPMCLZTFSA-N 0.000 title 1
108010051618 macrophage stimulatory lipopeptide 2 Proteins 0.000 title 1
125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 title 1
108010028921 Lipopeptides Proteins 0.000 abstract 1
102000004895 Lipoproteins Human genes 0.000 abstract 1
108090001030 Lipoproteins Proteins 0.000 abstract 1
208000032376 Lung infection Diseases 0.000 abstract 1
206010027476 Metastases Diseases 0.000 abstract 1
206010028980 Neoplasm Diseases 0.000 abstract 1
125000003342 alkenyl group Chemical group 0.000 abstract 1
125000000217 alkyl group Chemical group 0.000 abstract 1
125000000304 alkynyl group Chemical group 0.000 abstract 1
125000003275 alpha amino acid group Chemical group 0.000 abstract 1
229910052799 carbon Inorganic materials 0.000 abstract 1
125000004432 carbon atom Chemical group C* 0.000 abstract 1
208000037841 lung tumor Diseases 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Engineering & Computer Science (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Detergent Compositions (AREA)

DK01986301T 2000-10-02 2001-10-02 Anvendelse af S-[2,3-bispalmitoyloxy-(2RS)propyl]cysteinyl-GNNDESNISFKEK (MALP-2) DK1322321T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10048840A DE10048840A1 (de)	2000-10-02	2000-10-02	Verwendung von Lipopeptiden oder Lipoproteinen zur Behandlung von Lungeninfektionen und -tumoren
PCT/EP2001/011414 WO2002028887A2 (de)	2000-10-02	2001-10-02	Verwendung von lipopeptiden oder lipoproteinen zur behandlung von lungeninfektionen und -tumoren

Publications (1)

Publication Number	Publication Date
DK1322321T3 true DK1322321T3 (da)	2008-10-13

Family

ID=7658473

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK01986301T DK1322321T3 (da)	2000-10-02	2001-10-02	Anvendelse af S-[2,3-bispalmitoyloxy-(2RS)propyl]cysteinyl-GNNDESNISFKEK (MALP-2)

Country Status (10)

Country	Link
US (2)	US20040249133A1 (da)
EP (1)	EP1322321B1 (da)
JP (1)	JP4541642B2 (da)
AT (1)	ATE399018T1 (da)
AU (2)	AU2002220584B2 (da)
CA (1)	CA2424285A1 (da)
DE (2)	DE10048840A1 (da)
DK (1)	DK1322321T3 (da)
ES (1)	ES2309105T3 (da)
WO (1)	WO2002028887A2 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19652586A1 (de) *	1996-12-17	1998-06-18	Biotechnolog Forschung Gmbh	Dhc-Peptid und Mittel
AU2006259630B2 (en)	2005-06-13	2011-10-27	Cleveland Biolabs, Inc.	Methods of protecting against apoptosis using lipopeptides
DE102009034779A1 (de)	2009-07-25	2011-02-03	Emc Microcollections Gmbh	Synthetische Analoga bakterieller Lipopeptide und ihre Anwendung zur Therapie und Prophylaxe allergischer Erkrankungen
EP2305283A1 (en)	2009-09-24	2011-04-06	Helmholtz-Zentrum für Infektionsforschung GmbH	Pharmaceutical compositions for treating dysregulated inflammatory diseases
DE102011018499A1 (de)	2011-04-23	2012-10-25	Emc Microcollections Gmbh	Topische Nanopartikel-Vakzine zur Immunstimulation der dendritischen Zellen in der Haut

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0000330B1 (de) *	1977-06-20	1981-08-05	Ciba-Geigy Ag	Lipopeptide, Verfahren zu deren Herstellung und sie enthaltende pharmazeutische Präparate
JPH0499796A (ja) *	1990-08-13	1992-03-31	Kazuo Achinami	新規リポペプタイド及び抗腫瘍剤
DE19652586A1 (de) *	1996-12-17	1998-06-18	Biotechnolog Forschung Gmbh	Dhc-Peptid und Mittel
CA2295320A1 (en) *	1997-07-12	1999-01-21	Societe Des Produits Nestle S.A.	Coffee storage proteins
DE19822820A1 (de) *	1998-05-20	1999-11-25	Biotechnolog Forschung Gmbh	Pharmazeutisches Präparat zur Wundbehandlung

2000
- 2000-10-02 DE DE10048840A patent/DE10048840A1/de not_active Withdrawn
2001
- 2001-10-02 DK DK01986301T patent/DK1322321T3/da active
- 2001-10-02 AT AT01986301T patent/ATE399018T1/de active
- 2001-10-02 CA CA002424285A patent/CA2424285A1/en not_active Abandoned
- 2001-10-02 DE DE50114053T patent/DE50114053D1/de not_active Expired - Lifetime
- 2001-10-02 AU AU2002220584A patent/AU2002220584B2/en not_active Ceased
- 2001-10-02 US US10/398,094 patent/US20040249133A1/en not_active Abandoned
- 2001-10-02 AU AU2058402A patent/AU2058402A/xx active Pending
- 2001-10-02 EP EP01986301A patent/EP1322321B1/de not_active Expired - Lifetime
- 2001-10-02 ES ES01986301T patent/ES2309105T3/es not_active Expired - Lifetime
- 2001-10-02 WO PCT/EP2001/011414 patent/WO2002028887A2/de not_active Ceased
- 2001-10-02 JP JP2002532469A patent/JP4541642B2/ja not_active Expired - Fee Related
2003
- 2003-04-11 US US10/412,547 patent/US20040127405A1/en not_active Abandoned

Also Published As

Publication number	Publication date
AU2002220584B2 (en)	2007-08-09
US20040127405A1 (en)	2004-07-01
EP1322321A2 (de)	2003-07-02
US20040249133A1 (en)	2004-12-09
WO2002028887A2 (de)	2002-04-11
AU2058402A (en)	2002-04-15
CA2424285A1 (en)	2003-04-01
JP2004510783A (ja)	2004-04-08
DE10048840A1 (de)	2002-04-11
WO2002028887A3 (de)	2002-12-19
JP4541642B2 (ja)	2010-09-08
ES2309105T3 (es)	2008-12-16
ATE399018T1 (de)	2008-07-15
DE50114053D1 (de)	2008-08-07
EP1322321B1 (de)	2008-06-25
AU2002220584B8 (en)	2002-04-15

Similar Documents

Publication	Publication Date	Title
CY1107146T1 (el)	2012-05-23	Μεθοδοι για προληψη και θεραπεια ασθενειας alzheimer (ad)
NL300877I2 (nl)	2017-06-22	obeticholzuur
DE69926058D1 (de)	2005-08-11	Polyaminosäurederivate und ihre verwendung in zusammensetzungen zur behandlung von keratinischen fasern
BR0111596A (pt)	2004-03-02	Composto e seu uso, processo para sua produção, composição farmacêutica e processo e método para prevenir ou tratar doenças
CY1110446T1 (el)	2015-04-29	Χρηση (ζ)-2-κυανο-3-υδροξυ-βουτ-2-ενοϊκου οξεος-(4’-τριφθορομεθυλοφαινυλο)-αμιδης για τη θεραπεια πολλαπλης σκληρωσης
BR0210078A (pt)	2004-06-22	Composto, uso do mesmo, e, formulação farmacêutica
DK1404324T3 (da)	2008-03-31	Prolægemidler af GABA analoger, sammensætninger og anvendelser deraf
EA200300527A1 (ru)	2003-08-28	Новые способы лечения синдрома "усталых ног"
EA200201247A1 (ru)	2003-10-30	Соединения для лечения болезни альцгеймера
CY1109497T1 (el)	2014-08-13	Παραγωγα θειοφενιου ως αντιβιοτικοι παραγοντες για λοιμωξη/μολυνση φλαβοϊου (flavivirus)
MX9202287A (es)	1993-02-01	Nuevos derivados de perhidroisoindol, procedimiento para su preparacion y composicion farmaceutica que los contiene.
DK0775129T3 (da)	1999-06-28	3-Benzoylbenzofuranderivater som thyroidhormonantagonister
CO5210911A1 (es)	2002-10-30	Trifluorbutenos nematicidas
BR0008056A (pt)	2002-04-09	Pirrolocarbazóis e isoindolonas cìclicas fundidas substituìdas
BR0202397A (pt)	2003-04-29	Composição, utilização da mesma, processo de tratamento cosmético, e, utilização de pelo menos um éster n-acilado de aminoácido
EA200100983A1 (ru)	2002-10-31	Производные 13-метилэритромицина
ATE389395T1 (de)	2008-04-15	Substituierte 2-aminotetraline zur vorbeugenden behandlung von morbus parkinson
BR0113590A (pt)	2003-07-22	7-oxo-piridopirimidinas
BR0011728A (pt)	2002-02-26	Método de inibir a agregação de proteìna amilóide e imagem de depósitos de amilóide
BRPI0407441A (pt)	2006-01-31	4-[(2,4-dicloro-5-metóxifenil)amino]-6-alcóxi-3-quinoli nacarbonitrilos para o tratamento de lesão isquêmica
BR0104358A (pt)	2002-01-02	Formulações de taxana tendo solubilidade aperfeiçoada
DE50114053D1 (de)	2008-08-07	Verwendung von S-Ä2,3-Bispalmitoyloxy-(2RS)-propylÜcysteinyl-GNNDESNISFKEK (MALP-2)
DK1279677T3 (da)	2007-05-07	GD3-mimetiske peptider
BR0103710A (pt)	2002-04-09	Proteção de fibras queratinosas usando ceramidas e/ou glicoceramidas
SE9603285D0 (sv)	1996-09-10	New compounds